Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003793 · ClinicalTrials.gov registry record
Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 294
- Enrollment target
NCT00003793: Completed study, sponsored by Children's Oncology Group.
NCT00003793 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 294 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003793 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 294 participants
- Enrollment target
Study Summary
RATIONALE: Determination of genetic markers for soft tissue sarcoma or rhabdomyosarcoma may help doctors identify patients who are at risk for therapy-related leukemia. PURPOSE: Clinical trial to study genetic testing of children with soft tissue sarcoma or rhabdomyosarcoma to identify children who are at risk of developing leukemia from the chemotherapy used to treat sarcoma.
Interventions
- GENETIC mutation analysis
- GENETIC clonality analysis
- GENETIC microsatellite instability analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 294 participants |
| Start Date | 1998-12 |
| Est. Completion | 2007-03 |
What the finished NCT00003793 record still lists
NCT00003793 is an observational study that tracks outcomes without assigning an intervention. The registered 294 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which mutation analysis is the first listed.
NCT00003793 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003793 about?
NCT00003793 is a clinical study titled "Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma". RATIONALE: Determination of genetic markers for soft tissue sarcoma or rhabdomyosarcoma may help doctors identify patients who are at risk for therapy-related leukemia. PURPOSE: Clinical trial to study genetic testing of children with soft tissue sarcoma or rhabdomyosarcoma to identify children who...
What is the current status of trial NCT00003793?
This trial is currently completed. The enrollment target is 294 participants. The study started on 1998-12. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00003793?
The interventions under investigation include: mutation analysis (GENETIC), clonality analysis (GENETIC), microsatellite instability analysis (GENETIC).
Who is sponsoring clinical trial NCT00003793?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05775159 · 294 participants · Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- NCT06262113 · 294 participants · NA
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
- NCT06338865 · 294 participants · NA
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
- NCT06395467 · 294 participants · NA
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia